Detalhe da pesquisa
1.
Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)-sensitive and -resistant strains.
Drug Dev Res
; 85(3): e22194, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704828
2.
The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates.
Molecules
; 27(7)2022 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35408712
3.
Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives.
J Liposome Res
; 31(2): 169-176, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32228210
4.
Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284386
5.
American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
Trop Med Int Health
; 24(4): 380-391, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30681239
6.
Nanostructured Systems Improve the Antimicrobial Potential of the Essential Oil from Cymbopogon densiflorus Leaves.
J Nat Prod
; 82(12): 3208-3220, 2019 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31815454
7.
Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake.
Mem Inst Oswaldo Cruz
; 114: e190111, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433006
8.
Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine.
Parasitol Res
; 118(10): 3077-3084, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31401656
9.
Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis.
Antimicrob Agents Chemother
; 62(8)2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866873
10.
GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases.
Nanomedicine
; 14(3): 781-788, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278747
11.
A long-lasting oral preformulation of the angiotensin II AT1 receptor antagonist losartan.
Drug Dev Ind Pharm
; 44(9): 1498-1505, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29683352
12.
Mixed Formulation of Conventional and Pegylated Meglumine Antimoniate-Containing Liposomes Reduces Inflammatory Process and Parasite Burden in Leishmania infantum-Infected BALB/c Mice.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827416
13.
Silver and Nitrate Oppositely Modulate Antimony Susceptibility through Aquaglyceroporin 1 in Leishmania (Viannia) Species.
Antimicrob Agents Chemother
; 60(8): 4482-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27161624
14.
Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.
J Biol Inorg Chem
; 20(5): 771-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25929728
15.
Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid.
Antimicrob Agents Chemother
; 58(1): 481-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189251
16.
Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis.
Parasitol Res
; 113(2): 533-43, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24292604
17.
Mixed antimony(V) complexes with different sugars to modulate the oral bioavailability of pentavalent antimonial drugs.
Molecules
; 19(5): 5478-89, 2014 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24786687
18.
Novel triphenylantimony(V) and triphenylbismuth(V) complexes with benzoic acid derivatives: structural characterization, in vitro antileishmanial and antibacterial activities and cytotoxicity against macrophages.
Molecules
; 19(5): 6009-30, 2014 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24824136
19.
Development and characterization of multilamellar liposomes containing pyridostigmine.
Pharm Dev Technol
; 19(4): 454-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23682846
20.
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout.
Sci Rep
; 14(1): 6991, 2024 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523180